DISTINGUISHED LECTURE SERIES
The Distinguished Lecture Series was established to inspire students, doctors, and the public by inviting world-renowned doctors and researchers who have made a tremendous impact to share with us their experiences in lung cancer screening.
Dr. Gail Darling
Founder of Ontario's Lung Cancer Screening Pilot for People at High Risk and Professor and Director of Thoracic Surgery Clinical Research at Toronto General Hospital
Dr. Sam Janes
Director of the SUMMIT Study, the largest lung cancer screening study of its kind in the United Kingdom
Dr. Douglas Wood
Henry N. Harkins Professor and Chair of the Department of Surgery at the University of Washington
Dr. John Field
Chief Investigator of the first lung cancer CT Screening Trial in the United Kingdom
Dr. Stephen Lam
Professor of Medicine at the University of British Columbia, and the director of the MDS-Rix Early Lung Cancer Detection and Translational Research Program at the BC Cancer Research Center
Dr. Christine Berg
Co-Principal Investigator of the National Lung Screening Trial
Dr. Narjust Florez
Thoracic Medical Oncologist at Dana-Farber Brigham Cancer Center
Leader of IASLC "Lung Cancer Considered" Podcast, Principal Investigator of Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study
Dr. Bryant Lin
Co-Founder of Stanford University's Center for Asian Health Research and Education (CARE) as well as a primary care physician and professor of medicine at Stanford. Dr. Lin was also diagnosed with stage four lung cancer last May.
Dr. Ella Kazerooni
Professor of Radiology and Internal Medicine at the University of Michigan
​Chair of the American Cancer Society's National Lung Cancer Roundtable
Dr. Peter J. Mazzone
Pulmonologist at the Cleveland Clinic & Director of the Cleveland Clinic's Lung Cancer Screening Program​​
Editor in Chief of Chest Journal
Dr. David Baldwin
Leading respiratory physician on the UK CT lung cancer screening trial (UKLS).
Principal investigator on the Sputnik and SABRTooTH trials
Dr. Harry de Koning
Deputy Head and Professor of Public Health & Screening Evaluation at the Erasmus MC University Medical Centre; PI of the NELSON Trial